Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia

被引：0
|
作者：
Liu, Sining [1 ,2 ]
Cui, Qingya [1 ,2 ]
Li, Zheng [1 ,2 ]
Cui, Wei [1 ,2 ]
Li, Mengyun [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Xue, Shengli [1 ,2 ]
Chen, Suning [1 ,2 ]
Jin, Zhengming [1 ,2 ]
Miao, Miao [1 ,2 ]
Han, Yue [1 ,2 ]
Wang, Ying [1 ,2 ]
Zhu, Xiaming [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,4 ]
Tang, Xiaowen [1 ,2 ]
机构：
[1] First Affiliated Hosp Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy BioMed Technol Co Ltd, Shanghai, Peoples R China
[4] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Efficacy of Chidamide Maintenance Therapy after CAR-T Therapy for Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Huang, Lefu
    Zhang, Gailing
    Su, Yunchao
    Hu, Xiaona
    Xia, Shulian
    Li, Jingjing
    Lu, Peihua
    [J]. BLOOD, 2022, 140 : 8884 - 8885
  • [2] CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
    Vairy, Stephanie
    Garcia, Julia Lopes
    Teira, Pierre
    Bittencourt, Henrique
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3885 - 3898
  • [3] CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
    Testa, Ugo
    Sica, Simona
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [4] Predictive model for CAR-T cell therapy success in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia
    Pu, Lianfang
    Wang, Huiping
    Wu, Fan
    An, Furun
    Xiao, Hao
    Wang, Yangyang
    Liang, Xue
    Zhai, Zhimin
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024, 99 (04)
  • [5] Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant
    Cao, Xing-yu
    Zhang, Jian-ping
    Zhao, Yan-li
    Xiong, Min
    Zhou, Jia-rui
    Lu, Yue
    Sun, Rui-juan
    Wei, Zhi-jie
    Liu, De-yan
    Zhang, Xian
    Yang, Jun-fang
    Lu, Peihua
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Greinix, Hildegard T.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 36 - 42
  • [7] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Hildegard T. Greinix
    [J]. memo - Magazine of European Medical Oncology, 2020, 13 : 36 - 42
  • [8] Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia
    Cao Xinping
    Zhang Meng
    Guo Ruiting
    Zhang Xiaomei
    Sun Rui
    Xiao Xia
    Bai Xue
    Lyu Cuicui
    Pu Yedi
    Meng Juanxia
    Zhang Huan
    Zhu Haibo
    Liu Pengjiang
    Wang Zhao
    Zhang Yu
    Lu Wenyi
    Lyu Hairong
    Zhao Mingfeng
    [J]. 中华医学杂志英文版., 2025, 138 (01)
  • [9] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    [J]. IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [10] CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
    Pehlivan, Katherine C.
    Duncan, Brynn B.
    Lee, Daniel W.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (05) : 396 - 406
12345